This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$41.70
US$ Class I Dist
NAV per share 20.01.2021
£920.4mAUM

AUM 31.12.2020

Holdings
70.45% Active Share
As at 31.12.2020